

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * carnitine shuttle (GO:0006853) | 5.81900626 |
| 2 | * fatty acid transmembrane transport (GO:1902001) | 5.78119510 |
| 3 | regulation of sequestering of triglyceride (GO:0010889) | 5.74802673 |
| 4 | fatty acid beta-oxidation (GO:0006635) | 5.38470803 |
| 5 | tricarboxylic acid cycle (GO:0006099) | 5.37834005 |
| 6 | lysine catabolic process (GO:0006554) | 5.15114568 |
| 7 | lysine metabolic process (GO:0006553) | 5.15114568 |
| 8 | 2-oxoglutarate metabolic process (GO:0006103) | 4.95319591 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 4.94160842 |
| 10 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.74737574 |
| 11 | fatty acid catabolic process (GO:0009062) | 4.73457959 |
| 12 | fatty acid oxidation (GO:0019395) | 4.72644561 |
| 13 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.68570591 |
| 14 | * acetyl-CoA metabolic process (GO:0006084) | 4.68050169 |
| 15 | diacylglycerol metabolic process (GO:0046339) | 4.66382960 |
| 16 | regulation of fatty acid oxidation (GO:0046320) | 4.64138107 |
| 17 | lipid oxidation (GO:0034440) | 4.63179298 |
| 18 | regulation of triglyceride catabolic process (GO:0010896) | 4.46485255 |
| 19 | positive regulation of fatty acid oxidation (GO:0046321) | 4.45174437 |
| 20 | sarcomere organization (GO:0045214) | 4.41194255 |
| 21 | valine metabolic process (GO:0006573) | 4.39190715 |
| 22 | glycerolipid catabolic process (GO:0046503) | 4.36719150 |
| 23 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.36232230 |
| 24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.35121479 |
| 25 | brown fat cell differentiation (GO:0050873) | 4.32341704 |
| 26 | L-phenylalanine metabolic process (GO:0006558) | 4.31293270 |
| 27 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.31293270 |
| 28 | * carnitine transmembrane transport (GO:1902603) | 4.31257665 |
| 29 | NADH metabolic process (GO:0006734) | 4.28167849 |
| 30 | L-phenylalanine catabolic process (GO:0006559) | 4.27660533 |
| 31 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.27660533 |
| 32 | aspartate family amino acid catabolic process (GO:0009068) | 4.27195427 |
| 33 | branched-chain amino acid catabolic process (GO:0009083) | 4.26194340 |
| 34 | short-chain fatty acid metabolic process (GO:0046459) | 4.23224632 |
| 35 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.19694107 |
| 36 | monocarboxylic acid catabolic process (GO:0072329) | 4.18573487 |
| 37 | cellular response to epinephrine stimulus (GO:0071872) | 4.11897605 |
| 38 | glyoxylate metabolic process (GO:0046487) | 4.05727339 |
| 39 | amino-acid betaine metabolic process (GO:0006577) | 4.03568178 |
| 40 | * amino-acid betaine transport (GO:0015838) | 4.03099686 |
| 41 | * carnitine transport (GO:0015879) | 4.03099686 |
| 42 | branched-chain amino acid metabolic process (GO:0009081) | 4.02036970 |
| 43 | * biotin metabolic process (GO:0006768) | 3.96972007 |
| 44 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.96875964 |
| 45 | sulfur amino acid catabolic process (GO:0000098) | 3.96002656 |
| 46 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.95107990 |
| 47 | carnitine metabolic process (GO:0009437) | 3.94481087 |
| 48 | tricarboxylic acid metabolic process (GO:0072350) | 3.93262627 |
| 49 | lipid storage (GO:0019915) | 3.89865783 |
| 50 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.88643586 |
| 51 | cardiac myofibril assembly (GO:0055003) | 3.86017434 |
| 52 | response to epinephrine (GO:0071871) | 3.84638466 |
| 53 | ethanol metabolic process (GO:0006067) | 3.83772261 |
| 54 | fatty acid homeostasis (GO:0055089) | 3.81921227 |
| 55 | kynurenine metabolic process (GO:0070189) | 3.81343092 |
| 56 | regulation of cofactor metabolic process (GO:0051193) | 3.81027966 |
| 57 | regulation of coenzyme metabolic process (GO:0051196) | 3.81027966 |
| 58 | triglyceride biosynthetic process (GO:0019432) | 3.80335473 |
| 59 | cellular ketone body metabolic process (GO:0046950) | 3.77250691 |
| 60 | positive regulation of lipid catabolic process (GO:0050996) | 3.76664476 |
| 61 | actin-myosin filament sliding (GO:0033275) | 3.75401683 |
| 62 | muscle filament sliding (GO:0030049) | 3.75401683 |
| 63 | neutral lipid biosynthetic process (GO:0046460) | 3.73546829 |
| 64 | acylglycerol biosynthetic process (GO:0046463) | 3.73546829 |
| 65 | ethanol oxidation (GO:0006069) | 3.69713107 |
| 66 | oxaloacetate metabolic process (GO:0006107) | 3.69516604 |
| 67 | acylglycerol homeostasis (GO:0055090) | 3.68479554 |
| 68 | triglyceride homeostasis (GO:0070328) | 3.68479554 |
| 69 | myofibril assembly (GO:0030239) | 3.64723161 |
| 70 | lipid particle organization (GO:0034389) | 3.64531381 |
| 71 | aromatic amino acid family catabolic process (GO:0009074) | 3.64314422 |
| 72 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.64027463 |
| 73 | regulation of cholesterol storage (GO:0010885) | 3.63649971 |
| 74 | succinate metabolic process (GO:0006105) | 3.63233908 |
| 75 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.61208119 |
| 76 | phospholipid homeostasis (GO:0055091) | 3.60718497 |
| 77 | triglyceride catabolic process (GO:0019433) | 3.60037214 |
| 78 | triglyceride metabolic process (GO:0006641) | 3.54840334 |
| 79 | regulation of skeletal muscle contraction (GO:0014819) | 3.54631814 |
| 80 | * thioester biosynthetic process (GO:0035384) | 3.54030451 |
| 81 | * acyl-CoA biosynthetic process (GO:0071616) | 3.54030451 |
| 82 | positive regulation of glycolytic process (GO:0045821) | 3.52944747 |
| 83 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.52301619 |
| 84 | white fat cell differentiation (GO:0050872) | 3.50558698 |
| 85 | exogenous drug catabolic process (GO:0042738) | 3.49590885 |
| 86 | serine family amino acid catabolic process (GO:0009071) | 3.49554694 |
| 87 | low-density lipoprotein particle clearance (GO:0034383) | 3.49074536 |
| 88 | positive regulation of cholesterol efflux (GO:0010875) | 3.47911087 |
| 89 | neutral lipid catabolic process (GO:0046461) | 3.46047479 |
| 90 | acylglycerol catabolic process (GO:0046464) | 3.46047479 |
| 91 | carboxylic acid catabolic process (GO:0046395) | 3.43494484 |
| 92 | organic acid catabolic process (GO:0016054) | 3.43494484 |
| 93 | creatine metabolic process (GO:0006600) | 3.43030552 |
| 94 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.42764502 |
| 95 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.41709160 |
| 96 | plasma lipoprotein particle clearance (GO:0034381) | 3.40424266 |
| 97 | response to phenylpropanoid (GO:0080184) | 3.37327306 |
| 98 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.36353161 |
| 99 | acylglycerol metabolic process (GO:0006639) | 3.34161832 |
| 100 | alpha-amino acid catabolic process (GO:1901606) | 3.33345573 |
| 101 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.30527088 |
| 102 | positive regulation of cholesterol transport (GO:0032376) | 3.29390585 |
| 103 | positive regulation of sterol transport (GO:0032373) | 3.29390585 |
| 104 | neutral lipid metabolic process (GO:0006638) | 3.29144097 |
| 105 | bile acid biosynthetic process (GO:0006699) | 3.28663469 |
| 106 | drug catabolic process (GO:0042737) | 3.28013247 |
| 107 | complement activation, alternative pathway (GO:0006957) | 3.27251816 |
| 108 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.24968831 |
| 109 | regulation of triglyceride metabolic process (GO:0090207) | 3.24917920 |
| 110 | regulation of sulfur metabolic process (GO:0042762) | 3.24704989 |
| 111 | plasma membrane repair (GO:0001778) | 3.24220119 |
| 112 | ketone body metabolic process (GO:1902224) | 3.23081383 |
| 113 | glycogen catabolic process (GO:0005980) | 3.23056481 |
| 114 | glycerol metabolic process (GO:0006071) | 3.22811587 |
| 115 | cellular amino acid catabolic process (GO:0009063) | 3.22409659 |
| 116 | primary alcohol metabolic process (GO:0034308) | 3.20307376 |
| 117 | regulation of fatty acid metabolic process (GO:0019217) | 3.20015103 |
| 118 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.19380002 |
| 119 | cysteine metabolic process (GO:0006534) | 3.18814940 |
| 120 | urea metabolic process (GO:0019627) | 3.17778351 |
| 121 | urea cycle (GO:0000050) | 3.17778351 |
| 122 | * thioester metabolic process (GO:0035383) | 3.17567066 |
| 123 | * acyl-CoA metabolic process (GO:0006637) | 3.17567066 |
| 124 | epoxygenase P450 pathway (GO:0019373) | 3.17058635 |
| 125 | tryptophan catabolic process (GO:0006569) | 3.16248137 |
| 126 | indole-containing compound catabolic process (GO:0042436) | 3.16248137 |
| 127 | indolalkylamine catabolic process (GO:0046218) | 3.16248137 |
| 128 | cardiac muscle contraction (GO:0060048) | 3.16228600 |
| 129 | cardiac muscle cell development (GO:0055013) | 3.16156952 |
| 130 | positive regulation of lipid storage (GO:0010884) | 3.15614197 |
| 131 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.06650955 |
| 132 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.03698450 |
| 133 | growth hormone receptor signaling pathway (GO:0060396) | 3.03523614 |
| 134 | cGMP-mediated signaling (GO:0019934) | 2.99020443 |
| 135 | regulation of protein activation cascade (GO:2000257) | 2.97199740 |
| 136 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.96363625 |
| 137 | regulation of lipid storage (GO:0010883) | 2.96002292 |
| 138 | positive regulation of glomerulus development (GO:0090193) | 2.95599755 |
| 139 | regulation of complement activation (GO:0030449) | 2.94821424 |
| 140 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.94442084 |
| 141 | negative regulation of granulocyte differentiation (GO:0030853) | 2.93481599 |
| 142 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.92521894 |
| 143 | transcytosis (GO:0045056) | 2.91651014 |
| 144 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.89095761 |
| 145 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.89095761 |
| 146 | polyol transport (GO:0015791) | 2.84429535 |
| 147 | alditol metabolic process (GO:0019400) | 2.81516486 |
| 148 | negative regulation of lipase activity (GO:0060192) | 2.80318178 |
| 149 | protein heterotrimerization (GO:0070208) | 2.79927648 |
| 150 | negative regulation of lipid catabolic process (GO:0050995) | 2.78302318 |
| 151 | cellular response to growth hormone stimulus (GO:0071378) | 2.76998455 |
| 152 | omega-hydroxylase P450 pathway (GO:0097267) | 2.74320235 |
| 153 | regulation of lipid catabolic process (GO:0050994) | 2.74310134 |
| 154 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.74026758 |
| 155 | phosphatidic acid metabolic process (GO:0046473) | 2.71820563 |
| 156 | phosphatidic acid biosynthetic process (GO:0006654) | 2.71820563 |
| 157 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.71299906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 9.17606514 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.97351629 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.92594102 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.33326245 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.79090761 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.58467717 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.12753695 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.72774620 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.21582203 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.71246659 |
| 11 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.69531975 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.62434531 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.57559134 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.04129255 |
| 15 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.98508000 |
| 16 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.98508000 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.89221562 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.76397197 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.74969317 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.72770359 |
| 21 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.72443580 |
| 22 | * ZNF263_19887448_ChIP-Seq_K562_Human | 1.71511247 |
| 23 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.71284345 |
| 24 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.59810502 |
| 25 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.59000014 |
| 26 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.58049095 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.56257049 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.54986194 |
| 29 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.54147814 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.52066159 |
| 31 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.46083967 |
| 32 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.43035495 |
| 33 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.42708616 |
| 34 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.37142820 |
| 35 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.36181679 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.32418317 |
| 37 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.30525332 |
| 38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.29236081 |
| 39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27868214 |
| 40 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.23332585 |
| 41 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.22606568 |
| 42 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21866998 |
| 43 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.21711207 |
| 44 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.21461564 |
| 45 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.18436630 |
| 46 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.18378991 |
| 47 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.16754347 |
| 48 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.15375347 |
| 49 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.13367025 |
| 50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13185817 |
| 51 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.12298821 |
| 52 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.12179210 |
| 53 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.11757121 |
| 54 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10630438 |
| 55 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.10592096 |
| 56 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07131516 |
| 57 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.06923778 |
| 58 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.03993580 |
| 59 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.03993580 |
| 60 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.03909055 |
| 61 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.03339893 |
| 62 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03309727 |
| 63 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.02420652 |
| 64 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.02126865 |
| 65 | VDR_22108803_ChIP-Seq_LS180_Human | 1.01885967 |
| 66 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01045747 |
| 67 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01035383 |
| 68 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.00997851 |
| 69 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99093664 |
| 70 | CJUN_26792858_Chip-Seq_BT549_Human | 0.98800469 |
| 71 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.96834720 |
| 72 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.95763983 |
| 73 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95573633 |
| 74 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94979933 |
| 75 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94185169 |
| 76 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.94121510 |
| 77 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94101191 |
| 78 | STAT3_23295773_ChIP-Seq_U87_Human | 0.93035234 |
| 79 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.92377101 |
| 80 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92328666 |
| 81 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92328666 |
| 82 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.92287857 |
| 83 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.92190884 |
| 84 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.91406435 |
| 85 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.91378251 |
| 86 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90944893 |
| 87 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.90663469 |
| 88 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90242644 |
| 89 | GATA1_22025678_ChIP-Seq_K562_Human | 0.90198050 |
| 90 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.89477954 |
| 91 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.89118683 |
| 92 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88542439 |
| 93 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.87725699 |
| 94 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87679875 |
| 95 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.87009949 |
| 96 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85412950 |
| 97 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84845639 |
| 98 | ATF3_27146783_Chip-Seq_COLON_Human | 0.84162792 |
| 99 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.83601244 |
| 100 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83351992 |
| 101 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.83136975 |
| 102 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.82829421 |
| 103 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81570487 |
| 104 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81450464 |
| 105 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.81235620 |
| 106 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81016281 |
| 107 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.80752058 |
| 108 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.80500063 |
| 109 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.80494909 |
| 110 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.80292659 |
| 111 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.80247396 |
| 112 | AR_25329375_ChIP-Seq_VCAP_Human | 0.79754528 |
| 113 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.79640284 |
| 114 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.79249289 |
| 115 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.79240429 |
| 116 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.79110536 |
| 117 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.78619169 |
| 118 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.78244043 |
| 119 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.78046819 |
| 120 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77631622 |
| 121 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.76923243 |
| 122 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.76006262 |
| 123 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.75901423 |
| 124 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.75786708 |
| 125 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.75763636 |
| 126 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.74372538 |
| 127 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.73874239 |
| 128 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.73667381 |
| 129 | * P68_20966046_ChIP-Seq_HELA_Human | 0.73600868 |
| 130 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.72216573 |
| 131 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.71924156 |
| 132 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.71582103 |
| 133 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.71398324 |
| 134 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.71299636 |
| 135 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.70832971 |
| 136 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.70387836 |
| 137 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.70156816 |
| 138 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.69834771 |
| 139 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.69718370 |
| 140 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.69611123 |
| 141 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.68204080 |
| 142 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.67185044 |
| 143 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.67004362 |
| 144 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.66575491 |
| 145 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.65942823 |
| 146 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.65917298 |
| 147 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.65710724 |
| 148 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.65347084 |
| 149 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.63910107 |
| 150 | GATA2_19941826_ChIP-Seq_K562_Human | 0.63826715 |
| 151 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.63335405 |
| 152 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.63075783 |
| 153 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62617260 |
| 154 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62447399 |
| 155 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.60886472 |
| 156 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.60865175 |
| 157 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.60131747 |
| 158 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.59638499 |
| 159 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.59151027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.20295703 |
| 2 | MP0003646_muscle_fatigue | 4.22901939 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.19588064 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.67520985 |
| 5 | MP0005365_abnormal_bile_salt | 3.66583945 |
| 6 | MP0005360_urolithiasis | 3.64676760 |
| 7 | MP0005670_abnormal_white_adipose | 3.57893991 |
| 8 | MP0004130_abnormal_muscle_cell | 3.49179677 |
| 9 | MP0000751_myopathy | 3.37916025 |
| 10 | MP0004084_abnormal_cardiac_muscle | 3.12120283 |
| 11 | MP0005330_cardiomyopathy | 2.82025596 |
| 12 | MP0005666_abnormal_adipose_tissue | 2.79030249 |
| 13 | MP0004215_abnormal_myocardial_fiber | 2.71534741 |
| 14 | MP0004036_abnormal_muscle_relaxation | 2.62443056 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.59097622 |
| 16 | MP0000749_muscle_degeneration | 2.52748213 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.49084960 |
| 18 | MP0004087_abnormal_muscle_fiber | 2.27452041 |
| 19 | MP0008875_abnormal_xenobiotic_pharmacok | 2.21057338 |
| 20 | MP0004185_abnormal_adipocyte_glucose | 2.15763326 |
| 21 | MP0002876_abnormal_thyroid_physiology | 2.11120540 |
| 22 | MP0002269_muscular_atrophy | 2.02737149 |
| 23 | MP0003252_abnormal_bile_duct | 1.97763442 |
| 24 | MP0002971_abnormal_brown_adipose | 1.96842914 |
| 25 | MP0003011_delayed_dark_adaptation | 1.93621075 |
| 26 | MP0008775_abnormal_heart_ventricle | 1.91156344 |
| 27 | MP0005332_abnormal_amino_acid | 1.86662163 |
| 28 | MP0009840_abnormal_foam_cell | 1.86641632 |
| 29 | * MP0002118_abnormal_lipid_homeostasis | 1.86422985 |
| 30 | MP0000750_abnormal_muscle_regeneration | 1.84773362 |
| 31 | * MP0006036_abnormal_mitochondrial_physio | 1.83688765 |
| 32 | MP0005083_abnormal_biliary_tract | 1.83333564 |
| 33 | MP0010630_abnormal_cardiac_muscle | 1.82044270 |
| 34 | MP0005620_abnormal_muscle_contractility | 1.81073828 |
| 35 | MP0002972_abnormal_cardiac_muscle | 1.79360862 |
| 36 | MP0005375_adipose_tissue_phenotype | 1.79299632 |
| 37 | MP0005385_cardiovascular_system_phenoty | 1.73970009 |
| 38 | MP0001544_abnormal_cardiovascular_syste | 1.73970009 |
| 39 | MP0003705_abnormal_hypodermis_morpholog | 1.68920113 |
| 40 | MP0003137_abnormal_impulse_conducting | 1.67854862 |
| 41 | MP0006138_congestive_heart_failure | 1.64850665 |
| 42 | * MP0002106_abnormal_muscle_physiology | 1.63002743 |
| 43 | MP0002638_abnormal_pupillary_reflex | 1.61918704 |
| 44 | MP0000609_abnormal_liver_physiology | 1.59284797 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.56747178 |
| 46 | MP0000747_muscle_weakness | 1.54152680 |
| 47 | MP0000759_abnormal_skeletal_muscle | 1.51952263 |
| 48 | MP0004145_abnormal_muscle_electrophysio | 1.45514623 |
| 49 | MP0003221_abnormal_cardiomyocyte_apopto | 1.44601772 |
| 50 | * MP0005319_abnormal_enzyme/_coenzyme | 1.43746307 |
| 51 | MP0004233_abnormal_muscle_weight | 1.40770454 |
| 52 | MP0002332_abnormal_exercise_endurance | 1.40575884 |
| 53 | MP0003195_calcinosis | 1.38318093 |
| 54 | MP0003828_pulmonary_edema | 1.31921136 |
| 55 | MP0001666_abnormal_nutrient_absorption | 1.30800375 |
| 56 | * MP0005369_muscle_phenotype | 1.29440052 |
| 57 | MP0005334_abnormal_fat_pad | 1.28363132 |
| 58 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.23330124 |
| 59 | MP0003690_abnormal_glial_cell | 1.22304515 |
| 60 | MP0009780_abnormal_chondrocyte_physiolo | 1.21067471 |
| 61 | MP0009115_abnormal_fat_cell | 1.18054612 |
| 62 | MP0004484_altered_response_of | 1.16472806 |
| 63 | MP0005266_abnormal_metabolism | 1.11493570 |
| 64 | MP0005535_abnormal_body_temperature | 1.10871320 |
| 65 | * MP0002078_abnormal_glucose_homeostasis | 1.09067674 |
| 66 | MP0005451_abnormal_body_composition | 1.06373178 |
| 67 | MP0004085_abnormal_heartbeat | 1.01034728 |
| 68 | MP0010368_abnormal_lymphatic_system | 1.00835398 |
| 69 | MP0008438_abnormal_cutaneous_collagen | 1.00123126 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 0.98154883 |
| 71 | MP0006035_abnormal_mitochondrial_morpho | 0.98047764 |
| 72 | MP0000003_abnormal_adipose_tissue | 0.96077882 |
| 73 | MP0003879_abnormal_hair_cell | 0.94725333 |
| 74 | * MP0002970_abnormal_white_adipose | 0.93799723 |
| 75 | MP0005595_abnormal_vascular_smooth | 0.93143083 |
| 76 | MP0004019_abnormal_vitamin_homeostasis | 0.90577232 |
| 77 | MP0003724_increased_susceptibility_to | 0.88851173 |
| 78 | MP0000343_altered_response_to | 0.87132923 |
| 79 | MP0002127_abnormal_cardiovascular_syste | 0.86673077 |
| 80 | MP0005275_abnormal_skin_tensile | 0.83590576 |
| 81 | * MP0003953_abnormal_hormone_level | 0.83201507 |
| 82 | MP0005503_abnormal_tendon_morphology | 0.82585593 |
| 83 | MP0002909_abnormal_adrenal_gland | 0.82552483 |
| 84 | MP0000013_abnormal_adipose_tissue | 0.82222170 |
| 85 | MP0009643_abnormal_urine_homeostasis | 0.81410792 |
| 86 | MP0001501_abnormal_sleep_pattern | 0.80823684 |
| 87 | MP0003950_abnormal_plasma_membrane | 0.79287145 |
| 88 | MP0004272_abnormal_basement_membrane | 0.76530991 |
| 89 | MP0001764_abnormal_homeostasis | 0.76395302 |
| 90 | MP0003186_abnormal_redox_activity | 0.75627841 |
| 91 | MP0002108_abnormal_muscle_morphology | 0.72494978 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 0.72014407 |
| 93 | MP0001661_extended_life_span | 0.71757960 |
| 94 | MP0000598_abnormal_liver_morphology | 0.70699128 |
| 95 | MP0003567_abnormal_fetal_cardiomyocyte | 0.69962357 |
| 96 | * MP0000266_abnormal_heart_morphology | 0.68705324 |
| 97 | MP0000249_abnormal_blood_vessel | 0.68294303 |
| 98 | * MP0003948_abnormal_gas_homeostasis | 0.67415739 |
| 99 | MP0002254_reproductive_system_inflammat | 0.65990536 |
| 100 | * MP0005448_abnormal_energy_balance | 0.65862621 |
| 101 | MP0005376_homeostasis/metabolism_phenot | 0.65530613 |
| 102 | MP0005165_increased_susceptibility_to | 0.65516563 |
| 103 | MP0004510_myositis | 0.64325251 |
| 104 | MP0002295_abnormal_pulmonary_circulatio | 0.63980101 |
| 105 | MP0000230_abnormal_systemic_arterial | 0.63644706 |
| 106 | MP0002796_impaired_skin_barrier | 0.62931792 |
| 107 | MP0005647_abnormal_sex_gland | 0.60732792 |
| 108 | MP0003045_fibrosis | 0.60599849 |
| 109 | MP0003566_abnormal_cell_adhesion | 0.60512732 |
| 110 | MP0004043_abnormal_pH_regulation | 0.59140800 |
| 111 | MP0003279_aneurysm | 0.58657013 |
| 112 | * MP0005452_abnormal_adipose_tissue | 0.58216014 |
| 113 | MP0005164_abnormal_response_to | 0.58022701 |
| 114 | MP0003959_abnormal_lean_body | 0.56202885 |
| 115 | MP0008961_abnormal_basal_metabolism | 0.55055735 |
| 116 | MP0002128_abnormal_blood_circulation | 0.53881944 |
| 117 | MP0009763_increased_sensitivity_to | 0.53583760 |
| 118 | * MP0009642_abnormal_blood_homeostasis | 0.52335936 |
| 119 | MP0002138_abnormal_hepatobiliary_system | 0.49146571 |
| 120 | MP0003868_abnormal_feces_composition | 0.47948285 |
| 121 | MP0000579_abnormal_nail_morphology | 0.46929508 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myoglobinuria (HP:0002913) | 5.35260208 |
| 2 | Exercise-induced myalgia (HP:0003738) | 5.17238504 |
| 3 | Sudden death (HP:0001699) | 5.07007272 |
| 4 | Hyperglycinuria (HP:0003108) | 4.57025034 |
| 5 | Hypoglycemic coma (HP:0001325) | 4.52940479 |
| 6 | Ventricular tachycardia (HP:0004756) | 4.27465390 |
| 7 | Rhabdomyolysis (HP:0003201) | 4.27110811 |
| 8 | Exercise-induced muscle cramps (HP:0003710) | 4.21171768 |
| 9 | Muscle fiber splitting (HP:0003555) | 4.18520109 |
| 10 | Ketoacidosis (HP:0001993) | 4.17981289 |
| 11 | Ketosis (HP:0001946) | 4.17967741 |
| 12 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.16653778 |
| 13 | Hyperammonemia (HP:0001987) | 4.06149119 |
| 14 | Calf muscle hypertrophy (HP:0008981) | 4.02681979 |
| 15 | Abnormality of complement system (HP:0005339) | 4.01108391 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 3.96306600 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.96306600 |
| 18 | Hyporeflexia of lower limbs (HP:0002600) | 3.90283708 |
| 19 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.81388999 |
| 20 | Right ventricular cardiomyopathy (HP:0011663) | 3.68337966 |
| 21 | Dicarboxylic aciduria (HP:0003215) | 3.63167900 |
| 22 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.63167900 |
| 23 | Nemaline bodies (HP:0003798) | 3.60970064 |
| 24 | Increased connective tissue (HP:0009025) | 3.60538369 |
| 25 | Lipoatrophy (HP:0100578) | 3.53077909 |
| 26 | Hyperglycinemia (HP:0002154) | 3.45041820 |
| 27 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.44543772 |
| 28 | Xanthomatosis (HP:0000991) | 3.44273472 |
| 29 | Deep venous thrombosis (HP:0002625) | 3.43940775 |
| 30 | Difficulty running (HP:0009046) | 3.41292691 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 3.38982209 |
| 32 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.37834802 |
| 33 | Intrahepatic cholestasis (HP:0001406) | 3.31381710 |
| 34 | Palpitations (HP:0001962) | 3.21105177 |
| 35 | Asymmetric septal hypertrophy (HP:0001670) | 3.20709756 |
| 36 | Atrial fibrillation (HP:0005110) | 3.12950491 |
| 37 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.12761926 |
| 38 | Hyperlipoproteinemia (HP:0010980) | 3.12406710 |
| 39 | Abnormality of the calf musculature (HP:0001430) | 3.07204033 |
| 40 | Dilated cardiomyopathy (HP:0001644) | 2.99840179 |
| 41 | Hypolipoproteinemia (HP:0010981) | 2.99355600 |
| 42 | Subaortic stenosis (HP:0001682) | 2.90711160 |
| 43 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.90711160 |
| 44 | Atrioventricular block (HP:0001678) | 2.89396083 |
| 45 | Primary atrial arrhythmia (HP:0001692) | 2.87242003 |
| 46 | Increased muscle lipid content (HP:0009058) | 2.85157035 |
| 47 | Joint hemorrhage (HP:0005261) | 2.81546473 |
| 48 | Hemorrhage of the eye (HP:0011885) | 2.80614972 |
| 49 | Pigmentary retinal degeneration (HP:0001146) | 2.80390880 |
| 50 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.79996238 |
| 51 | Hypobetalipoproteinemia (HP:0003563) | 2.79367490 |
| 52 | Systemic lupus erythematosus (HP:0002725) | 2.79333098 |
| 53 | EMG: myopathic abnormalities (HP:0003458) | 2.76470249 |
| 54 | Hepatic necrosis (HP:0002605) | 2.76265973 |
| 55 | Supraventricular tachycardia (HP:0004755) | 2.75386709 |
| 56 | Cerebral edema (HP:0002181) | 2.75188896 |
| 57 | Muscle stiffness (HP:0003552) | 2.74582995 |
| 58 | Frequent falls (HP:0002359) | 2.71958180 |
| 59 | Supraventricular arrhythmia (HP:0005115) | 2.71753151 |
| 60 | Abnormality of alanine metabolism (HP:0010916) | 2.71563748 |
| 61 | Hyperalaninemia (HP:0003348) | 2.71563748 |
| 62 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.71563748 |
| 63 | Bundle branch block (HP:0011710) | 2.70115688 |
| 64 | Glomerulonephritis (HP:0000099) | 2.69627418 |
| 65 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.68538842 |
| 66 | Insulin resistance (HP:0000855) | 2.63799227 |
| 67 | Syncope (HP:0001279) | 2.63372206 |
| 68 | Epidermoid cyst (HP:0200040) | 2.62703022 |
| 69 | Facial shape deformation (HP:0011334) | 2.62159216 |
| 70 | Potter facies (HP:0002009) | 2.62159216 |
| 71 | Heart block (HP:0012722) | 2.60719144 |
| 72 | Complement deficiency (HP:0004431) | 2.60460261 |
| 73 | Rimmed vacuoles (HP:0003805) | 2.59239880 |
| 74 | Ventricular arrhythmia (HP:0004308) | 2.53676040 |
| 75 | Myotonia (HP:0002486) | 2.52444010 |
| 76 | Generalized aminoaciduria (HP:0002909) | 2.52275432 |
| 77 | Type 1 muscle fiber predominance (HP:0003803) | 2.51115578 |
| 78 | Lethargy (HP:0001254) | 2.51013289 |
| 79 | Metabolic acidosis (HP:0001942) | 2.47754130 |
| 80 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.43754546 |
| 81 | Abnormal atrioventricular conduction (HP:0005150) | 2.43590424 |
| 82 | Abnormality of serum amino acid levels (HP:0003112) | 2.39950914 |
| 83 | Prolonged partial thromboplastin time (HP:0003645) | 2.38615736 |
| 84 | Muscle fiber inclusion bodies (HP:0100299) | 2.37343040 |
| 85 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.33822539 |
| 86 | Skin nodule (HP:0200036) | 2.33152719 |
| 87 | Cholelithiasis (HP:0001081) | 2.32542216 |
| 88 | Hyperglycemia (HP:0003074) | 2.30615582 |
| 89 | Gowers sign (HP:0003391) | 2.28840687 |
| 90 | Generalized muscle weakness (HP:0003324) | 2.26850805 |
| 91 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.26584558 |
| 92 | Difficulty climbing stairs (HP:0003551) | 2.21574686 |
| 93 | Nausea (HP:0002018) | 2.19021866 |
| 94 | Abnormal gallbladder morphology (HP:0012437) | 2.18795243 |
| 95 | Nephritis (HP:0000123) | 2.18180428 |
| 96 | Oligomenorrhea (HP:0000876) | 2.16871747 |
| 97 | EMG: neuropathic changes (HP:0003445) | 2.16313593 |
| 98 | Infantile muscular hypotonia (HP:0008947) | 2.14591938 |
| 99 | Increased serum pyruvate (HP:0003542) | 2.12152629 |
| 100 | Prolonged QT interval (HP:0001657) | 2.11482502 |
| 101 | Lymphangioma (HP:0100764) | 2.07192847 |
| 102 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.06864385 |
| 103 | Acute encephalopathy (HP:0006846) | 2.06547597 |
| 104 | Vomiting (HP:0002013) | 2.06272830 |
| 105 | Conjunctival hamartoma (HP:0100780) | 2.05558545 |
| 106 | Hyperkalemia (HP:0002153) | 2.05387648 |
| 107 | Distal lower limb muscle weakness (HP:0009053) | 2.02819033 |
| 108 | Ragged-red muscle fibers (HP:0003200) | 2.02693305 |
| 109 | Hypertriglyceridemia (HP:0002155) | 1.99827072 |
| 110 | Polycythemia (HP:0001901) | 1.99102687 |
| 111 | Abnormality of purine metabolism (HP:0004352) | 1.98264345 |
| 112 | Abnormality of proline metabolism (HP:0010907) | 1.98224093 |
| 113 | Hydroxyprolinuria (HP:0003080) | 1.98224093 |
| 114 | Hypercholesterolemia (HP:0003124) | 1.97545406 |
| 115 | Increased variability in muscle fiber diameter (HP:0003557) | 1.97414251 |
| 116 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.96807803 |
| 117 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.96642145 |
| 118 | Testicular atrophy (HP:0000029) | 1.96540321 |
| 119 | Renal cortical cysts (HP:0000803) | 1.95274681 |
| 120 | Lactic acidosis (HP:0003128) | 1.94140031 |
| 121 | Myocardial infarction (HP:0001658) | 1.93876662 |
| 122 | Decreased circulating renin level (HP:0003351) | 1.93429537 |
| 123 | Prominent supraorbital ridges (HP:0000336) | 1.92612765 |
| 124 | Hypoglycemic seizures (HP:0002173) | 1.91391711 |
| 125 | Delayed CNS myelination (HP:0002188) | 1.90849051 |
| 126 | Neck muscle weakness (HP:0000467) | 1.90319258 |
| 127 | Gout (HP:0001997) | 1.89581819 |
| 128 | Acanthosis nigricans (HP:0000956) | 1.89206517 |
| 129 | Scapular winging (HP:0003691) | 1.87833846 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.91486536 |
| 2 | TTN | 3.97813108 |
| 3 | TRIB3 | 3.82030324 |
| 4 | OBSCN | 3.58004166 |
| 5 | PDK4 | 3.47698649 |
| 6 | PDK3 | 3.47698649 |
| 7 | PHKG1 | 3.21587469 |
| 8 | PHKG2 | 3.21587469 |
| 9 | SIK1 | 2.84570547 |
| 10 | PKN2 | 2.78793281 |
| 11 | PINK1 | 2.62648283 |
| 12 | FRK | 2.53299757 |
| 13 | CAMK1D | 2.51868167 |
| 14 | EPHA3 | 2.36147491 |
| 15 | LMTK2 | 2.24454781 |
| 16 | PDK2 | 2.12651385 |
| 17 | CAMK1 | 1.95700892 |
| 18 | ICK | 1.95249359 |
| 19 | MYLK | 1.73415822 |
| 20 | TIE1 | 1.73238441 |
| 21 | CAMK1G | 1.68802644 |
| 22 | NLK | 1.63944162 |
| 23 | INSRR | 1.62948947 |
| 24 | NEK1 | 1.60786113 |
| 25 | DMPK | 1.58192732 |
| 26 | ERN1 | 1.56421251 |
| 27 | PIK3CA | 1.46177819 |
| 28 | FGFR4 | 1.43614592 |
| 29 | RIPK1 | 1.36929700 |
| 30 | MAP3K6 | 1.32320917 |
| 31 | PDGFRA | 1.25396469 |
| 32 | AKT3 | 1.22529863 |
| 33 | MAP3K7 | 1.20286923 |
| 34 | LATS1 | 1.19910370 |
| 35 | FLT3 | 1.18282924 |
| 36 | * PRKAA2 | 1.13791039 |
| 37 | SGK2 | 1.11845892 |
| 38 | MAP2K3 | 1.11247197 |
| 39 | EPHB2 | 1.09332218 |
| 40 | MAPK11 | 1.06855110 |
| 41 | * PRKAA1 | 1.03492545 |
| 42 | EEF2K | 1.00128393 |
| 43 | MAPK12 | 0.96488144 |
| 44 | DDR2 | 0.96048354 |
| 45 | PRKD1 | 0.94019718 |
| 46 | STK38L | 0.92656512 |
| 47 | MAP3K11 | 0.89918932 |
| 48 | MARK1 | 0.88881710 |
| 49 | PIK3CG | 0.87805291 |
| 50 | MUSK | 0.86616374 |
| 51 | FER | 0.83419419 |
| 52 | MAPK7 | 0.82361276 |
| 53 | GRK1 | 0.81518498 |
| 54 | DAPK2 | 0.81367285 |
| 55 | CAMKK2 | 0.81238651 |
| 56 | PRKG1 | 0.80538653 |
| 57 | MAPKAPK3 | 0.78917854 |
| 58 | SGK494 | 0.78057260 |
| 59 | SGK223 | 0.78057260 |
| 60 | KDR | 0.77963312 |
| 61 | TGFBR2 | 0.75240575 |
| 62 | LATS2 | 0.74955711 |
| 63 | MAP3K3 | 0.73487225 |
| 64 | ADRBK1 | 0.73330475 |
| 65 | STK11 | 0.72650751 |
| 66 | MAPK15 | 0.72464389 |
| 67 | TRPM7 | 0.71127400 |
| 68 | MTOR | 0.70341023 |
| 69 | PTK6 | 0.67208034 |
| 70 | NTRK3 | 0.64017577 |
| 71 | EPHB1 | 0.61054199 |
| 72 | CAMK2D | 0.60594680 |
| 73 | STK24 | 0.60267388 |
| 74 | IGF1R | 0.59766584 |
| 75 | NEK9 | 0.59718383 |
| 76 | MAP2K4 | 0.57895667 |
| 77 | WNK4 | 0.57730172 |
| 78 | KIT | 0.57290620 |
| 79 | MARK2 | 0.56984060 |
| 80 | MST1R | 0.55837011 |
| 81 | PAK3 | 0.55652662 |
| 82 | PDPK1 | 0.55508557 |
| 83 | CSK | 0.55298782 |
| 84 | CDC42BPA | 0.55255823 |
| 85 | STK38 | 0.54410842 |
| 86 | MAP2K6 | 0.53771833 |
| 87 | MAPK3 | 0.53613369 |
| 88 | DYRK1B | 0.53424629 |
| 89 | GSK3A | 0.53320354 |
| 90 | * PRKACG | 0.52541750 |
| 91 | JAK2 | 0.52358356 |
| 92 | RPS6KC1 | 0.52317883 |
| 93 | RPS6KL1 | 0.52317883 |
| 94 | BMX | 0.52189848 |
| 95 | ILK | 0.51726852 |
| 96 | ACVR1B | 0.50067410 |
| 97 | PRKD2 | 0.49918143 |
| 98 | CDK6 | 0.48985141 |
| 99 | MAP3K5 | 0.48635930 |
| 100 | PRKCE | 0.47081935 |
| 101 | IRAK1 | 0.46654156 |
| 102 | MAP3K10 | 0.46460337 |
| 103 | JAK1 | 0.45903438 |
| 104 | WNK1 | 0.45369145 |
| 105 | STK39 | 0.44778767 |
| 106 | RPS6KA6 | 0.43735967 |
| 107 | OXSR1 | 0.43509031 |
| 108 | ADRBK2 | 0.43053718 |
| 109 | WNK3 | 0.42836498 |
| 110 | TYRO3 | 0.41439234 |
| 111 | CAMK4 | 0.41300272 |
| 112 | BMPR1B | 0.40756921 |
| 113 | CAMK2G | 0.40553967 |
| 114 | PDK1 | 0.38700483 |
| 115 | MAPK4 | 0.36718515 |
| 116 | AKT2 | 0.35942957 |
| 117 | PKN1 | 0.35187300 |
| 118 | RPS6KA1 | 0.34810102 |
| 119 | FGFR3 | 0.34386868 |
| 120 | GRK7 | 0.33808702 |
| 121 | ROCK1 | 0.33688270 |
| 122 | STK4 | 0.33074053 |
| 123 | ERBB4 | 0.32539011 |
| 124 | PRKACB | 0.30703112 |
| 125 | TYK2 | 0.30311591 |
| 126 | SGK3 | 0.29814485 |
| 127 | PRKACA | 0.28441431 |
| 128 | CDK4 | 0.27195202 |
| 129 | PDGFRB | 0.26889313 |
| 130 | FGFR2 | 0.25713368 |
| 131 | MET | 0.24956252 |
| 132 | ABL2 | 0.24394468 |
| 133 | RET | 0.23455889 |
| 134 | MAP2K1 | 0.21493379 |
| 135 | RPS6KA3 | 0.20521786 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.94744333 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.65531440 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.63324193 |
| 4 | * Propanoate metabolism_Homo sapiens_hsa00640 | 3.59979456 |
| 5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.35045812 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.33251287 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.30819833 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.78483576 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.57552043 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.53579308 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.34659504 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.28856148 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.25604911 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.24508004 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.23314621 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.21931273 |
| 17 | * Pyruvate metabolism_Homo sapiens_hsa00620 | 2.04775536 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.92527711 |
| 19 | * Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.89731573 |
| 20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.86306287 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.78917244 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.78190469 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.55153348 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.53646263 |
| 25 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.43082322 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.38706105 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.38061731 |
| 28 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.35918010 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.34226954 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.25416993 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.23575905 |
| 32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.22035723 |
| 33 | Lysine degradation_Homo sapiens_hsa00310 | 1.19460095 |
| 34 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.14797149 |
| 35 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.12382945 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11458679 |
| 37 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.10475345 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.10055372 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.01532670 |
| 40 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.00745176 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.00474317 |
| 42 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.00451757 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00334738 |
| 44 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.93856804 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 0.93600521 |
| 46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.93229457 |
| 47 | Renin secretion_Homo sapiens_hsa04924 | 0.92788724 |
| 48 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.88977923 |
| 49 | Histidine metabolism_Homo sapiens_hsa00340 | 0.85732071 |
| 50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85348448 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.84592266 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 0.84511484 |
| 53 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84079842 |
| 54 | * Insulin resistance_Homo sapiens_hsa04931 | 0.81748489 |
| 55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.81107383 |
| 56 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.79814049 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 0.79368852 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78867480 |
| 59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.78667941 |
| 60 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.75986324 |
| 61 | Parkinsons disease_Homo sapiens_hsa05012 | 0.75012925 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73501646 |
| 63 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.71245740 |
| 64 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.70404428 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69921118 |
| 66 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.68444045 |
| 67 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65476370 |
| 68 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63930247 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.62373714 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62284451 |
| 71 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.62027013 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59799000 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59154495 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58868290 |
| 75 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58010313 |
| 76 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.57121721 |
| 77 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.56334633 |
| 78 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.53162652 |
| 79 | Alzheimers disease_Homo sapiens_hsa05010 | 0.48958950 |
| 80 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.43154963 |
| 81 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.41353406 |
| 82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40569835 |
| 83 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37509964 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.36857570 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36611398 |
| 86 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34646519 |
| 87 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.34041608 |
| 88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.34003614 |
| 89 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.31275585 |
| 90 | Huntingtons disease_Homo sapiens_hsa05016 | 0.30184943 |
| 91 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.29338153 |
| 92 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.28960660 |
| 93 | Insulin secretion_Homo sapiens_hsa04911 | 0.28381959 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.27856459 |
| 95 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.27801871 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27705990 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26420658 |
| 98 | Circadian rhythm_Homo sapiens_hsa04710 | 0.24506939 |
| 99 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.23498509 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.23023292 |
| 101 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.22930356 |
| 102 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.22228348 |
| 103 | Morphine addiction_Homo sapiens_hsa05032 | 0.20931248 |
| 104 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.18496262 |
| 105 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.16036467 |
| 106 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.15921552 |
| 107 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.15004650 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.13891013 |
| 109 | Circadian entrainment_Homo sapiens_hsa04713 | 0.13593975 |
| 110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.13514490 |
| 111 | Salivary secretion_Homo sapiens_hsa04970 | 0.12952981 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.10967938 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.10661154 |
| 114 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.07555710 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.06182623 |
| 116 | Focal adhesion_Homo sapiens_hsa04510 | 0.03160075 |
| 117 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.01029563 |
| 118 | Adherens junction_Homo sapiens_hsa04520 | 0.00662014 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0172501 |

